Sanofi GCVRZ 深 滬
等待開盤 09-17 09:30:00 美东时间
0.8711
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.8711
- 總市值 1113.52亿
- 52周最高 0.882
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.43
- 委 比 0.00%
- 總股本 1278.30亿
- 歷史最高 0.882
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.153
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Five new members added to CDC vaccine advisory panel
The U.S. Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) have added five new members to the CDC Advisory Committee on Immunization Practices (ACI...
09-16 20:00
Former Trump surgeon general says RFK Jr. must go
Jerome Adams, who served as U.S. surgeon general during the first Trump administration, said that Robert F. Kennedy Jr.'s time as HHS secretary "has been a failure" and he should leave the agency. Spe...
09-15 23:07
SA Asks: Which biotechs could be acquired by year's end?
The fourth quarter has historically been a busy time for the biopharma industry, with the sector generally seeing a significant uptick in M&A activity. We asked Seeking Alpha analysts Stephen Ayers ...
09-14 04:18
Sanofi Investigational Gene Therapy SAR402663 Wins FDA Fast Track Status To Treat Neovascular Age Related Macular Degeneration
Sanofi's SAR402663 earns fast track designation in the US for neovascular age-related macular degenerationDesignation earned for a one-time intravitreal gene therapy with the potential to eliminate treatment burden for
09-11 13:30
Waystar announces 18M-share secondary offering
Waystar Holding (NASDAQ:WAY) announced a secondary offering of 18M shares of common stock. Waystar is not selling any shares and will not receive proceeds from the offering. Shares will be sold via an...
09-11 04:51
14亿美元！心血管药企并购+1
（来源：动脉新医药） 2025年9月9日，瑞士制药巨头诺华（Novartis）宣布以约14亿美元的现金交易，收购美国临床阶段公司Tourmaline Bio。这...
09-10 18:28
Three key points from the new MAHA report
The Trump administration’s Make America Healthy Again Commission released its second report on Tuesday, noting that dietary factors, synthetic chemicals, lack of physical activity, and over-prescripti...
09-10 03:21
Morgan Stanley Upgrades Sanofi to Overweight, Raises Price Target to $58
Morgan Stanley analyst Mark Purcell upgrades Sanofi (NASDAQ:SNY) from Equal-Weight to Overweight and raises the price target from $56 to $58.
09-08 18:37
Sanofi’s Promising Crohn’s Disease Study: What Investors Need to Know
Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Study Ov...
09-08 00:58
Sanofi Stock (SNY) Crashes 9% after Eczema Drug Trial Data Disappoints
Shares in French drugmaker Sanofi ($SNY) sickened today as trial data on a new ...
09-05 06:58
